The little blue pill has a new rival. GlaxoSmithKline PLC and Bayer AG won U.S. approval on Tuesday to sell the anti-impotence drug Levitra, setting the stage for a fierce battle with Viagra in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results